SCHEMBL7147242

SCHEMBL7147242

COc1cc(NC(=O)OC(C)(C)C)c(NC(=O)CC(=O)c2cccc(-n3ccnc3)c2)cc1-c1ccc(F)cc1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 1/20 0.41
GRM2 Q14416 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
ABCB1 P08183 2/20 0.35
CYP3A4 P08684 2/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
KDM4D Q6B0I6 1/20 0.35
CYP17A1 P05093 2/20 0.34
PDE4A P27815 1/20 0.34
PDE4B Q07343 1/20 0.34
PDE4C Q08493 1/20 0.34
PDE4D Q08499 1/20 0.34
HCRTR1 O43613 1/20 0.34
HCRTR2 O43614 1/20 0.34
ADH5 P11766 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7139934 0.94 ABL1 (0.41) ABL1L3MBTL1KDM4DCYP17A1PDE4A
SCHEMBL7145881 0.93 ABL1 (0.39) ABL1L3MBTL1ABCB1CYP3A4KDM4D
SCHEMBL7140968 0.92 ABL1 (0.38) ABL1L3MBTL1CYP3A4ALDH1A1MAPT
SCHEMBL7145856 0.91 ABL1 (0.38) ABL1L3MBTL1CYP3A4ALDH1A1MAPT
SCHEMBL7146597 0.91 ADH5 (0.41) ABL1L3MBTL1KDM4DCYP17A1PDE4A
SCHEMBL7141902 0.91 ABL1 (0.37) ABL1L3MBTL1KDM4DCYP17A1PDE4A
SCHEMBL7141809 0.91 ABL1 (0.40) ABL1L3MBTL1MEN1KMT2AABCB1
SCHEMBL7143394 0.90 ADH5 (0.40) ABL1L3MBTL1MAPTKDM4DCYP17A1
SCHEMBL7143167 0.90 ABL1 (0.41) ABL1L3MBTL1MEN1KMT2AABCB1
SCHEMBL5868843 0.88 CYP17A1 (0.42) ABL1L3MBTL1CYP3A4KDM4DCYP17A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224174-B1 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2003-09-17 EP disclosed
US-6407094-B1 4-5-DIDEHYDRO-1,5-BENZODIAZEPIN-2-ONE DERIVATIVES; PSYCHOLOGICAL, NERVOUS SYSTEM, AND BRAIN DISORDERS; COGNITION ACTIVATORS; ALZHEIMER*S DISEASE, SCHIZOPHRENIA HOFFMANN-LA ROCHE INC. 2002-06-18 US disclosed